What You Should Know:
– BrightInsight, Inc., a provider of regulated digital health solutions, has announced an expanded multi-year partnership with Sanofi, a global biopharmaceutical company. This expanded partnership builds on a successful collaboration that…
Continue Reading
Converge Bio has raised $5.5 million in seed funding led by TLV Partners.WHAT IT DOES
Converge Bio is a generative AI hub for Biotech and Pharma that allows the accelerated discovery and development of drugs…
What You Should Know:
– Converge Bio, a generative AI platform for accelerated drug discovery and development, today announced it has raised $5.5 million in seed funding, led by TLV Partners.
– Converge Bio’s platform uses large language…
Continue Reading
What You Should Know:
– GeneDx, a leader in genomic insights, has announced the launch of GeneDx Discover, a groundbreaking data visualization tool designed to revolutionize drug discovery and development.
– The platform provides biopharmaceutical companies…
Continue Reading
Emmanuelle Hose GVP & General Manager – EMEA at Rimini Street
The healthcare industry is in a transformative era driven by artificial intelligence (AI). This technology is revolutionizing healthcare delivery, from accelerating drug discovery and…
Continue Reading
What You Should Know:
– NVIDIA announced widespread adoption of its open-source BioNeMo™ Framework by pharmaceutical companies, techbio innovators, and AI researchers to accelerate drug discovery and molecule design.
– The framework provides a powerful suite…
Continue Reading
A consortium of research institutes in South Korea has been formed to promote the utilisation of AI and national supercomputers in discovering novel drugs for treating lung cancer.According to a press statement, the following organisations will…
Continue Reading
Noah Nasser, CEO, datma
The healthcare industry is a wellspring of data, from electronic health records to data from wearables, health insurance claims, and a multitude of real-world data (RWD) points. While RWD has been…
Continue Reading
What You Should Know:
– Genesis Therapeutics, a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for patients, announced today a further equity investment from NVentures, NVIDIA’s venture capital arm.
– This investment is in addition…
Continue Reading
Digital biology company Optic is collaborating with early-stage oncology therapeutics venture, Vindur Tx, to use Optics proprietary generative AI platform to find novel highly selective kinase inhibitors and develop more effective cancer treatments. Vindur Tx…
Continue Reading
